$1.68
-0.06-3.45%
al cierre: -
$1.74
0.063.57%
After hour: 8:49 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Coherus Oncology informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 5
Estimación de BPA
$-0.330
Estimación de ingresos trimestrales
$12.93M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$272.21M
Analice el historial de beneficios de Coherus Oncology utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CHRS | Coherus BioSciences | -$0.01 | -$0.33 | — | — | $70.77M | $12.93M | — | — | 11/05/2025 | |
CHRS | Coherus BioSciences | -$0.14 | -$0.26 | -$0.34 | -30.77% | $10.30M | $9.62M | $10.25M | 6.64% | 08/07/2025 | |
CHRS | Coherus BioSciences | -$0.48 | -$0.13 | -$0.35 | -169.23% | $2.31M | $54.70M | $7.60M | -86.11% | 05/12/2025 | |
CHRS | Coherus BioSciences | -$0.62 | -$0.13 | -$0.28 | -115.38% | $91.52M | $43.88M | $54.14M | 23.39% | 03/10/2025 | |
CHRS | Coherus BioSciences | -$0.27 | -$0.12 | -$0.01 | 91.67% | $74.57M | $59.23M | $70.77M | 19.49% | 11/06/2024 | |
CHRS | Coherus BioSciences | -$0.38 | -$0.16 | -$0.14 | 12.50% | $58.72M | $64.16M | $64.98M | 1.28% | 08/08/2024 | |
CHRS | Coherus BioSciences | -$0.75 | -$0.24 | -$0.32 | -33.33% | $32.44M | $80.25M | $77.06M | -3.97% | 05/09/2024 | |
CHRS | Coherus BioSciences | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | 03/13/2024 | |
CHRS | Coherus BioSciences | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | 11/06/2023 | |
CHRS | Coherus BioSciences | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | 08/02/2023 | |
CHRS | Coherus BioSciences | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | 05/08/2023 | |
CHRS | Coherus BioSciences | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | 03/06/2023 | |
CHRS | Coherus BioSciences | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | 11/08/2022 | |
CHRS | Coherus BioSciences | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | 08/04/2022 | |
CHRS | Coherus BioSciences | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | 05/05/2022 | |
CHRS | Coherus BioSciences | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | 02/17/2022 | |
CHRS | Coherus BioSciences | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | 11/08/2021 | |
CHRS | Coherus BioSciences | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | 08/05/2021 | |
CHRS | Coherus BioSciences | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | 05/06/2021 | |
CHRS | Coherus BioSciences | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | 02/24/2021 | |
CHRS | Coherus BioSciences | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | 11/05/2020 |
Coherus Oncology (CHRS) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $-0.34 | $-0.26 | -30.8 % |
| Q1 | 2025-05-12 | $-0.35 | $-0.13 | -169.2 % |
| Q4 | 2025-03-10 | $-0.28 | $-0.13 | -115.4 % |
| Q3 | 2024-11-06 | $-0.01 | $-0.12 | 91.7 % |
Coherus Oncology (CHRS) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $10.25M | $9.62M | 6.64 % |
| Q1 | 2025-05-12 | $7.60M | $54.70M | -86.1 % |
| Q4 | 2025-03-10 | $54.14M | $43.88M | 23.4 % |
| Q3 | 2024-11-06 | $70.77M | $59.23M | 19.5 % |
PREGUNTAS FRECUENTES
¿Cuándo Coherus Oncology (NASDAQ:CHRS) publicará los resultados?
Está previsto que Coherus Oncology (CHRS) presente resultados el noviembre 5, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Coherus Oncology (NASDAQ:CHRS)?
El BPA real fue de $-0.34, que no alcanzó la estimación de $-0.26.
¿Cuáles fueron los ingresos de Coherus Oncology (NASDAQ:CHRS)?
Los ingresos reales fueron $10.3M, que superó la estimación de $9.6M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.